Sungboon Editor Daily Invisible Blurring Sunscreen
NDC 85037-002, Avobenzone, Homosalate, Octisalate, Octocrylene, cream, from Olive International Inc..
- Product NDC
- 85037-002
- Status
- Listed
- Labeler
- Olive International Inc.
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85037-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AVOBENZONE29 mg/mL
- HOMOSALATE100 mg/mL
- OCTISALATE49 mg/mL
- OCTOCRYLENE90 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85037-002-02 | 85037000202 | 1 TUBE in 1 CARTON (85037-002-02) / 50 mL in 1 TUBE (85037-002-01) |
| 85037-002-04 | 85037000204 | 1 TUBE in 1 CARTON (85037-002-04) / 12 mL in 1 TUBE (85037-002-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 85037-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85037-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85037-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.